Skip to main content
. 2016 Jan 21;27(8):2467–2473. doi: 10.1681/ASN.2015060661

Table 1.

Baseline characteristics of participants with eGFR≥60 ml/min per 1.73m2

Participant Characteristics Q1 Q2 Q3 Q4 P value
n 2265 2264 2265 2264
Age, mean (SD) 56.5 (5.8) 56.5 (5.7) 56.5 (5.6) 56.8 (5.6) 0.06
Sex, female, % (n) 56.7 (1284) 57.4 (1299) 57.3 (1298) 55.7 (1260) 0.62
Race, black, % (n) 19.6 (443) 20.4 (461) 22.3 (504) 20.3 (459) 0.14
eGFR, ml/min per 1.73 m2, mean (SD) 97.2 (14.3) 97.5 (14.0) 97.7 (13.6) 97.4 (13.4) 0.55
Prevalent diabetes, % (n) 17.6 (398) 14.3 (324) 12.5 (283) 11.6 (263) <0.001
Prevalent hypertension, % (n) 35.3 (799) 33.3 (755) 33.3 (755) 32.9 (745) 0.33
Smoking status, % (n) <0.001
 Current smoker 30.7 (696) 25.4 (574) 20.9 (473) 18.2 (412)
 Former smoker 34.3 (777) 36.8 (834) 39 (883) 39.4 (892)
 Never smoked 35 (792) 37.8 (856) 40.1 (909) 42.4 (960)
Prevalent coronary heart disease, % (n) 6.5 (147) 4.9 (112) 4.7 (106) 3.2 (72) <0.001
BMI, kg/m2, mean (SD) 27.7 (5.4) 28.1 (5.5) 27.9 (5.3) 27.9 (5.3) 0.39
WBC count, 103/μl, median (1st, 3rd quartile) 6.4 (5.3, 7.7) 6.0 (5, 7.2) 5.6 (4.8, 6.7) 5.3 (4.5, 6.4) <0.001
HbA1c, median (1st, 3rd quartile)a 5.4 (5.2, 5.9) 5.4 (5.2, 5.8) 5.4 (5.2, 5.8) 5.4 (5.2, 5.8) 0.93
Serum albumin, mean (SD)a 4.18 (0.29) 4.18 (0.29) 4.19 (0.28) 4.18 (0.28) 0.40
hsCRP, median (1st, 3rd quartile)a 2.4 (1.1, 5.3) 2.4 (1.1, 4.8) 2.1 (1.0, 4.7) 2.0 (1.0, 4.1) <0.001

n=9058.

a

Variables are available at visit two only (n=8135).

HHS Vulnerability Disclosure